IS IT SAFE TO OMIT THE 37-DEGREES-C READING FROM PRETRANSFUSION RED-BLOOD-CELL ANTIBODY DETECTION TESTING

Citation
Jp. Pestaner et Ia. Shulman, IS IT SAFE TO OMIT THE 37-DEGREES-C READING FROM PRETRANSFUSION RED-BLOOD-CELL ANTIBODY DETECTION TESTING, American journal of clinical pathology, 101(3), 1994, pp. 361-364
Citations number
19
Categorie Soggetti
Pathology
ISSN journal
00029173
Volume
101
Issue
3
Year of publication
1994
Pages
361 - 364
Database
ISI
SICI code
0002-9173(1994)101:3<361:IISTOT>2.0.ZU;2-2
Abstract
The routine pretransfusion red blood cell antibody detection test (PAD T), performed at the authors' institution, consists of a three-phase, saline-antiglobulin technique (immediate spin, 30-minute incubation at 37 degrees C, IgG indirect antihuman globulin test [IAT]), and each p hase is examined for hemolysis and agglutination. To determine if it w ould be safe to omit reading the 37 degrees C phase of the PADT, a 6-y ear retrospective review of records (February 1986 to February 1992) w as undertaken. Of approximately 280,000 sera tested for unexpected red cell alloantibodies, 1480 (.53%) were reactive at only 37 degrees C. Of 1480 sera, 1313 contained alloantibodies of no or questionable sign ificance leg, anti-Le(a), anti-le(b), anti-P-1), 71 sera contained ant ibodies of undetermined specificity, and 10 sera were reactive because of rouleaux. Eighty-six serum samples from 53 different patients cont ained alloantibodies of potential significance (anti-K, anti-E, etc). These 86 sera represented approximately 2.2% of all reactive sera that contained potentially significant alloantibodies. Although most antib odies (approximately 94%) detected only at 37 degrees C were of no or questionable significance, the other 6% could have increased the risk of missing a potentially significant antibody from approximately 1 in every 4700 sera tested to 1 in every 1875 sera tested, had they not be en detected. The authors suggest that the increased risk of an acute o r delayed hemolytic transfusion reaction would be too high to justify a procedural change. Based on these data, the authors continue to read the 37 degrees C phase of the PADT for hemolysis and agglutination.